Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD Share Price
Equities
300534
CNE100002CP5
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.23 CNY | +0.98% | +3.26% | -16.62% |
Sales 2022 | 413M 57.07M 4.76B | Sales 2023 | 1.08B 149M 12.44B | Capitalization | 2.99B 414M 34.5B |
---|---|---|---|---|---|
Net income 2022 | 25M 3.45M 288M | Net income 2023 | 61M 8.42M 703M | EV / Sales 2022 | 6.27 x |
Net cash position 2022 | 97.83M 13.51M 1.13B | Net cash position 2023 | 144M 19.94M 1.66B | EV / Sales 2023 | 2.64 x |
P/E ratio 2022 |
104
x | P/E ratio 2023 |
48.6
x | Employees | 763 |
Yield 2022 * |
-
| Yield 2023 |
0.2% | Free-Float | 59.9% |
1 day | +0.98% | ||
1 week | +3.26% | ||
1 month | -2.83% | ||
3 months | +11.07% | ||
6 months | -15.85% | ||
Current year | -16.62% |
Managers | Title | Age | Since |
---|---|---|---|
Shuang Xi Qian
CEO | Chief Executive Officer | 39 | 10/23/10 |
Zheng Choi Zhao
DFI | Director of Finance/CFO | 37 | 01/09/01 |
Yong Hong Kang
BRD | Director/Board Member | 48 | 03/02/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qin Hui Yuan
BRD | Director/Board Member | 49 | 29/12/29 |
Zong Yi Li
BRD | Director/Board Member | 54 | 30/20/30 |
Kan Ren Zhou
BRD | Director/Board Member | 48 | 10/17/10 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 8.23 | +0.98% | 7,340,000 |
29/24/29 | 8.15 | +2.26% | 7,332,200 |
26/24/26 | 7.97 | +0.89% | 6,497,700 |
25/24/25 | 7.9 | +0.51% | 5,819,400 |
End-of-day quote Shenzhen S.E., April 30, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.62% | 345M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- 300534 Stock